Migliori M - Search Results

1

High-volume online haemodiafiltration improves erythropoiesis-stimulating agent (ESA) resistance in comparison with low-flux bicarbonate dialysis: results of the REDERT study.

Panichi V, Scatena A, Rosati A, Giusti R, Ferro G, Malagnino E, Capitanini A, Piluso A, Conti P, Bernabini G, Migliori M, Caiani D, Tetta C, Casani A, Betti G, Pizzarelli F. Panichi V, et al. Among authors: migliori m. Nephrol Dial Transplant. 2015 Apr;30(4):682-9. doi: 10.1093/ndt/gfu345. Epub 2014 Nov 10. Nephrol Dial Transplant. 2015. PMID: 25385719 Clinical Trial.

2

C-reactive protein and interleukin-6 levels are related to renal function in predialytic chronic renal failure.

Panichi V, Migliori M, De Pietro S, Taccola D, Bianchi AM, Giovannini L, Norpoth M, Metelli MR, Cristofani R, Bertelli AA, Sbragia G, Tetta C, Palla R, Colombo R. Panichi V, et al. Among authors: migliori m. Nephron. 2002 Aug;91(4):594-600. doi: 10.1159/000065018. Nephron. 2002. PMID: 12138260

3

Effects of calcitriol on the immune system: new possibilities in the treatment of glomerulonephritis.

Panichi V, Migliori M, Taccola D, Consani C, Giovannini L. Panichi V, et al. Among authors: migliori m. Clin Exp Pharmacol Physiol. 2003 Nov;30(11):807-11. doi: 10.1046/j.1440-1681.2003.03919.x. Clin Exp Pharmacol Physiol. 2003. PMID: 14678241 Review.

4

Interleukin-6 is a stronger predictor of total and cardiovascular mortality than C-reactive protein in haemodialysis patients.

Panichi V, Maggiore U, Taccola D, Migliori M, Rizza GM, Consani C, Bertini A, Sposini S, Perez-Garcia R, Rindi P, Palla R, Tetta C. Panichi V, et al. Among authors: migliori m. Nephrol Dial Transplant. 2004 May;19(5):1154-60. doi: 10.1093/ndt/gfh052. Epub 2004 Feb 19. Nephrol Dial Transplant. 2004. PMID: 14993508

5

Ceruloplasmin and acute phase protein levels are associated with cardiovascular disease in chronic dialysis patients.

Panichi V, Taccola D, Rizza GM, Consani C, Migliori M, Filippi C, Paoletti S, Sidoti A, Borracelli D, Panicucci E, Giovannini L. Panichi V, et al. Among authors: migliori m. J Nephrol. 2004 Sep-Oct;17(5):715-20. J Nephrol. 2004. PMID: 15593040

6

Interleukin-8 is a powerful prognostic predictor of all-cause and cardiovascular mortality in dialytic patients.

Panichi V, Taccola D, Rizza GM, Consani C, Ghiadoni L, Filippi C, Cristofani R, Panicucci E, Migliori M, Sidoti A, Biagioli M, Boracelli D, Barsotti G, Tetta C. Panichi V, et al. Among authors: migliori m. Nephron Clin Pract. 2006;102(2):c51-8. doi: 10.1159/000088923. Epub 2005 Oct 13. Nephron Clin Pract. 2006. PMID: 16224196

7

Neutralization of macrophage-stimulating protein ameliorates renal injury in anti-thy 1 glomerulonephritis.

Rampino T, Soccio G, Gregorini M, Guidetti C, Marasà M, Maggio M, Panichi V, Migliori M, Libetta C, Dal Canton A. Rampino T, et al. Among authors: migliori m. J Am Soc Nephrol. 2007 May;18(5):1486-96. doi: 10.1681/ASN.2006060680. Epub 2007 Apr 4. J Am Soc Nephrol. 2007. PMID: 17409315

8

Chronic inflammation and mortality in haemodialysis: effect of different renal replacement therapies. Results from the RISCAVID study.

Panichi V, Rizza GM, Paoletti S, Bigazzi R, Aloisi M, Barsotti G, Rindi P, Donati G, Antonelli A, Panicucci E, Tripepi G, Tetta C, Palla R; RISCAVID Study Group. Panichi V, et al. Nephrol Dial Transplant. 2008 Jul;23(7):2337-43. doi: 10.1093/ndt/gfm951. Epub 2008 Feb 27. Nephrol Dial Transplant. 2008. PMID: 18305316

9

Impact of calcium, phosphate, PTH abnormalities and management on mortality in hemodialysis: results from the RISCAVID study.

Panichi V, Bigazzi R, Paoletti S, Mantuano E, Beati S, Marchetti V, Bernabini G, Grazi G, Giust R, Rosati A, Migliori M, Pasquariello A, Panicucci E, Barsotti G, Bellasi A; RISCAVID Study Group. Panichi V, et al. Among authors: migliori m. J Nephrol. 2010 Sep-Oct;23(5):556-62. J Nephrol. 2010. PMID: 20349412

10

A vitamin E-coated polysulfone membrane reduces serum levels of inflammatory markers and resistance to erythropoietin-stimulating agents in hemodialysis patients: results of a randomized cross-over multicenter trial.

Panichi V, Rosati A, Paoletti S, Ferrandello P, Migliori M, Beati S, Bernabini G, Daini R, Casani A, Angelini D, Parrini M, Rossi A, Petrone I, Barsotti G, Donadio C, Donati G, Grazi G, Manca Rizza G, Garosi G, Sansoni E, Braccagni B, Sidoti A, Boracelli D, Biagioli M, Moriconi L, Finato V, Mannarino A, Grimaldi C, Pansa F, Imperiali P, Mura C, Bianchi S, Bigazzi R. Panichi V, et al. Among authors: migliori m. Blood Purif. 2011;32(1):7-14. doi: 10.1159/000321369. Epub 2011 Jan 14. Blood Purif. 2011. PMID: 21242686 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

235 results

Search Page

Filters